Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

132.44 +1.19 (+0.91%)
Official Closing Price Updated: 4:10 PM EDT, Aug 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
47 48 Next >
NIKE To Rally Over 23%? Here Are 10 Other Analyst Forecasts For Thursday
Keybanc raised the price target for D.R. Horton, Inc. (NYSE: DHI) from $97 to $109. Keybanc analyst Kenneth Zener maintained an Overweight rating. D.R. Horton shares fell 1.6% to close at $95.48 on... 
Via Benzinga
Abbott's Sales and Earnings Are Sinking: Should Investors Worry?
There's more to the story than the negative trends for Abbott's top and bottom lines. 
Via The Motley Fool
Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
Johnson & Johnson and Abbott Laboratories are 2 dividend kings guiding for growth in 2023 and are on track to increase their yield yet again. 
Via MarketBeat
Topics Economy
Why Abbott Laboratories Stock Got Whacked on Wednesday
Double beats for its latest quarter couldn't keep the bears away from the company's shares on Hump Day. 
Via The Motley Fool
Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript
ABT earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
 
Via Benzinga
What's Going On With Abbott Laboratories Stock Today?
Abbott Laboratories (NYSE: ABT) shares are trading lower Wednesday in the wake of the company's quarterly results. 
Via Benzinga
Abbott Laboratories Skids As Covid Testing Weighs On Organic Growth
Overall sales topped forecasts, but organic growth missed expectations. 
Via Investor's Business Daily
Why Aurora Cannabis Stock Is Fading Today
With discretionary spending under pressure, investors are shying away from this Canadian cannabis stock today. 
Via The Motley Fool
Abbott Q4 Earnings And Revenues Top Estimates
Abbott came out with quarterly earnings of $1.03 per share. 
Via Talk Markets
Microsoft's Gloomy Guidance, Boeing's Surprise Q4 Loss Pulls Market Lower
(Wednesday Market Open) The market gives and the market takes away. 
Via Benzinga
Nasdaq Futures Slump As Microsoft's Outlook Dampens Tech Recovery Expectations — Analyst Warns Of More Bumpiness By Mid-February
U.S. stocks look set to start Wednesday’s session on the back foot as traders digest mixed earnings news flow and continued pouring in of weak economic data points. Cues From Tuesday’s Trading: 
Via Benzinga
A Bullish Sign Appears On Abbott Laboratories's Chart
 
Via Benzinga
Earnings Outlook For Abbott Laboratories
 
Via Benzinga
FDA Approves Abbott's Next-Gen Navitor TAVI System For Aortic Stenosis
 
Via Benzinga
Earnings Scheduled For January 25, 2023
Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is expected to report quarterly earnings at $4.45 per share on revenue of $6.50 billion. 
Via Benzinga
Investor Optimism Declines Following Earnings Reports
The CNN Money Fear and Greed index showed some decline in overall market sentiment among US investors. US stocks closed mixed on Tuesday as investors assessed the latest corporate earnings. 
Via Benzinga
Abbott Laboratories, QUALCOMM, GE HealthCare Technologies And This Subsidiary Of Diamondback Energy On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Viper Energy Partners LP (NASDAQ: VNOM), which is a subsid 
Via Benzinga
Stocks Make a Quiet Move Upward Ahead of Thursday's GDP, 'Pause' Talk
(Monday Market Open) This week and next could go a long way toward determining how the current quarter plays out on Wall Street. 
Via Benzinga
Spotify To Downsize Employee Count, Activist Investor Elliott Invests Multibillion Dollars In Salesforce, Abbott Draws DOJ Investigation On Baby Formula Plant Shutdown: Today's Top Stories
Reuters Juul's Consumer Settlement Is 'Reasonable & Adequate,' US Judge Says 
Via Benzinga
Want Safe and Growing Passive Income? Buy These 2 Dividend Kings In 2023
It doesn't get any safer for income investors than Dividend Kings. 
Via The Motley Fool
6 Dividend Growth Stocks
Interested in knowing about companies that are paying their shareholders even bigger dividends than before? Today I want to tell you about six dividend growth stocks that just increased their... 
Via Talk Markets
Tesla, Microsoft, IBM, Intel, TI Among Companies Reporting This Week: Can Netflix's Optimism Spill Over To Rest Of Tech Space?
Netflix, Inc. (NASDAQ: NFLX) shares jumped nearly 8.5% on Friday before settling at their highest level since April 19, 2022, when shares plunged after the company reported its first loss in net paid... 
Via Benzinga
Abbott Laboratories Under DOJ Investigation Into 2022 Baby Formula Plant Shutdown: Report
The Justice Department's consumer-protection branch is conducting an investigation into infant formula maker Abbott Laboratories (NYSE: ABT). 
Via Benzinga
ABBOTT ALERT: Bragar Eagel & Squire, P.C. is Investigating Abbott Laboratories on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
3 Top Passive-Income Stocks to Own in 2023
These stocks can add safety and growth to your portfolio. 
Via The Motley Fool
AbbVie Stock: Dividend King ABBV Overview
Via MarketBeat
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing. 
Via Talk Markets
Zoetis, SL Green Realty, Abbott Laboratories And This Big Bank Reporting Earnings On Friday: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named Zoetis Inc. 
Via Benzinga
Should You Buy This Promising New Healthcare Stock?
Shares of GE Healthcare began trading last week after the company completed its spinoff from General Electric. 
Via The Motley Fool
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
47 48 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.